Fibroblast growth factor 1 (FGF1) induces proliferation and dierentiation in a wide variety of cells of mesodermal and neuroectodermal origin. FGF1 has nò classical' signal sequence to direct its secretion, and there has been considerable debate concerning FGF1 secretion and its role in the biological activities of FGF1. We investigated the eects of FGF1 secretion and the signalling induced by signal peptide (SP)-containing FGF1 and SP-less FGF1, on the proliferation and the apoptosis in retinal pigmented epithelial (RPE) cells. Primary RPE cell cultures were transfected with FGF1 (FGF1 cells) and SP-FGF1 (SP-FGF1 cells) cDNAs. SP-FGF1 cells secreted large amount of FGF1 and actively proliferated, whereas FGF1 and control cells did not. Secreted FGF1 induced short-term activation of both FGFR1 and ERK2, which were required for cell proliferation. In contrast, SP-FGF1 cells stopped secreting FGF1 and died rapidly, if cultured in the absence of serum. Surprisingly, FGF1 cells, but not control cells, secreted FGF1 and were resistant to apoptosis induced by serum depletion. Secreted FGF1 induced long-term activation of FGFR1 and ERK2, which was necessary to induce a constant and high level of Bcl-x production, and to induce cell survival in FGF1 cells. Downregulation of ERK2 and Bcl-x increased apoptosis. Thus, the proliferation and survival activities of FGF1 depend on the secretion of FGF1 which is determined by the cell culture conditions. Cell proliferation was SP-dependent, whereas cell survival was not. The signal peptide controls the level and duration, whispering or shouting', of ERK2 activation cells which determines FGF1 biological function and may have important implications for anti-degenerative and antiproliferative treatments. Oncogene (2000) 19, 4917 ± 4929.
Introduction
Fibroblast growth factor 1 (FGF1) belongs to a family of at least 22 growth factors and oncogenes that play important roles in various physiological and pathological processes, including embryonic development, cell growth, in¯ammation, angiogenesis and tumour growth and invasion (reviewed in Mason, 1994) .
FGF1 is a mitogenic factor for a wide variety of cells derived from the mesoderm and neuroectoderm, including retina cells (Burgess and Maciag, 1989) . All cell layers in normal adult retina produce FGF1, as cells no longer dierentiate or proliferate. Injury to the retina, in which the neural retina is separated from the retinal pigmented epithelium (RPE), induced RPE cell proliferation, leading to proliferative retinopathy (Hjelmeland et al., 1988) . RPE cells produce low basal levels of FGF1 . High levels of FGF1 production in proliferative RPE cells have been correlated with proliferative vitreoretinopathy (Malecaze et al., 1993) . High levels of FGFs production and secretion have been detected in cells derived from pigment cell tumours and RPE-associated choroidal melanomas in humans (Enzman et al., 1998) . FGFs have been proposed as candidate regulatory molecules in the response of the retina to injury (Bradshaw et al., 1990; Lewis et al., 1992) . The potential role of endogenous FGFs in regulating the proliferation of RPE after retina injury has been demonstrated in vivo (Lewis et al., 1992) . However, little is known about the mechanisms underlying endogenous FGFs-mediated RPE cell proliferation. Although FGF1 is not secreted via the classical secretion pathway, there is evidence that it is secreted from the cell via an alternative pathway, and subsequently act as an autocrine or paracrine factor (Vlodavski et al., 1982; Sato and Rifkin, 1988) . Exogenous FGF1 acts by binding to and phosphorylating the FGF tyrosine kinase receptor (FGFR) and by activating transiently the extracellular signal-regulated kinases (ERKs). Although RPE cells are unable to divide in vivo, they may require survival factors to inhibit their apoptosis. The survival of RPE cells is critical to the maintenance of retina function. In retinal dystrophy in rat, cell apoptosis is prevented by a single subretinal injection of exogenous FGF1, demonstrating that FGF1 can act as a survivalpromoting trophic factor in the retina in vivo (Faktorovich et al., 1990) . In previous studies, we have shown that ERK2 is rapidly and transiently activated by exogenous FGF1 in proliferating RPE cells (Guillonneau et al., 1998a) , whereas an increase in the production of endogenous FGF1 is correlated with the sustained activation and expression of ERK2 and a decrease in apoptosis in non-proliferating quiescent RPE cells during in vitro ageing (Guillonneau et al., 1998b) . These data suggest that exogenous FGF1 is a mitogenic factor, whereas endogenous FGF1 may be an anti-apoptotic factor. These studies also indicated that FGF1 paracrine and intracrine pathways supporting RPE cell proliferation and survival, may depend upon the kinetics of ERK2 activation. This, led us to think that both the level of ERK2 expression and the extent of ERK2 activation might be regulated by the extent to which endogenous FGF1 was excreted. We, therefore studied the direct eects of FGF1 on the proliferation and survival of RPE cells, by overproducing human FGF1 or the signal peptide (SP)-FGF1 conjugate. We investigated several aspects of FGF signalling, including the secretion of FGF1, FGFR phosphorylation, ERK2 activation and the production of anti-apoptotic members of the Bcl-2 protein family in FGF1-transfected RPE cells.
Results

Differential expression, production and secretion of FGF1 by RPE cells transfected with human FGF1 cDNAs
Primary RPE cells transfected with pSVL alone (control cells) cultures did not express detectable amounts of FGF1 mRNA before day 6 of culture in the presence of serum ( Figure 1a ). RPE cells transfected with the FGF1 cDNA (FGF1 cells) expressed high levels of FGF1 transcript which remained high over a 6-day culture period. Similar results were obtained with SP-FGF1-transfected cells (SP-FGF1). We compare FGF1/NR ratios and found that FGF1 and SP-FGF cells synthesized seven to twelve times more FGF1 mRNA than control cells ( Figure 1b) . Analysis of the de novo synthesis of FGF1 showed that control RPE cells synthesized very small amounts of FGF1, only on day 5 of the culture, whereas both FGF1 and SP-FGF1 cells synthesized higher levels of FGF1 over the 5-day period of culture ( Figure 1c) . Analysis of intracellular FGF1 by Western blotting showed that control cells did not produce any detectable FGF1 before day 7 of culture in the presence of serum (Figure 2a ). In contrast, FGF1 and SP-FGF1 cells produced large amounts of FGF1 after 1 day of culture and over the entire 7-day period of culture. Thus large amounts of recombinant FGF1 were synthesized in FGF1 and SP-FGF1 cells. No FGF1 was detected in the extracellular culture media of control ( Figure 2b ) and untransfected (data not shown) cells cultured in the presence of serum. As expected, there was no FGF1 in the culture media of FGF1 cells. Only SP-FGF1 cells secreted large amounts of FGF1 into the culture medium after 1 day of culture in the presence of serum and throughout the 7-day culture period. Immunohistochemical studies detected a very weak anti-FGF1 signal in the untransfected and control RPE cells ( Figure 2c ). As expected, FGF1 cells were labelled with the anti-FGF1 antibody, with FGF1 labelling homogeneous throughout the cell. In contrast, FGF1 staining was very intense in the nucleus of SP-FGF1 cells. Incubation of the anti-FGF1 antibody with its Figure 1 Kinetics of FGF1 mRNA and protein synthesis in control and FGF1-expressing RPE cells. Total RNA (1 mg; a and b) and total protein (100 ng; c) extracted on the day indicated after transfection of control, FGF1-transfected (FGF1) and SP-FGF1 (SP-FGF1)-transfected RPE cells were used to analyse the gene expression and protein synthesis for FGF1 respectively, as described in Materials and methods. GAPDH mRNA analysis shows equal levels of expression over the 6-day period of culture (data not shown). The data in b are the relative amounts of FGF1 mRNA normalized relative to the amount of nitrate reductase (NR) mRNA, and values are means+s.d., (c) All lanes were run on the same gel, but irrelevant lanes were removed to improve clarity. These experiments correspond to one of three independent RT ± PCRs with dierent RNA extracts (a and b) and independent FGF1 immunoprecipitations with dierent protein extracts (c), that gave similar results cognate antigen results in the absence of staining (data not shown).
Proliferation of RPE cells is dependent on FGF1 secretion and transient ERK2 activation
Control cells and FGF1-transfected cells grew with similar kinetics in the presence of serum (Figure 3a) , and had a doubling time of 72 h. These cells reached con¯uence after 3 days of culture and were contact inhibited. They kept their classical epithelial morphology ( Figure 3b ). In contrast, SP-FGF1-transfected RPE cells proliferated more rapidly. Their doubling time was 36 h (Figure 3a) . After 3 days of culture, there were 85% more SP-FGF1 cells than FGF1 or control cells. SP-FGF1 cells also lost their typical epithelial morphology, becoming ®broblast-like and lost their contact inhibition (Figure 3b ). Neutralization of secreted FGF1 by addition of neutralizing anti-FGF1 antibody to the culture medium reduced the proliferation of SP-FGF1 cells to a level similar to that of control and FGF1-cells, suggesting that the proliferation of SP-FGF1-transfected RPE cells was mediated by secreted FGF1 (Figure 3c ). The addition of the neutralizing anti-FGF1 antibody to the culture medium did not signi®cantly aect the proliferation of control and FGF1 cells.
The paracrine mitogenic activity of the FGF1 produced and secreted by RPE cells depends on the activation of FGFR and ERK in RPE cells (Guillonneau et al., 1998) . We therefore assessed autophosphorylation of FGFR1 (the only FGF tyrosine-kinase receptor at the bovine RPE cell surface), after FGF1 transfection. FGFR1 did not undergo detectable tyrosine phosphorylation in FGF1 cells, whereas it underwent a strong activation over 6 h of culture in SP-FGF1 cells (Figure 4a ). The level of FGFR1 autophosphorylation in SP-FGF1 cells was similar to that for native RPE cells stimulated with exogenous FGF1 for 10 min (Figure 4a,b) . A neutralizing anti-FGF1 antibody inhibited FGFR1 autophosphorylation in cultures of SP-FGF1 cells (Figure 4b ), indicating that the sustained FGFR1 activation detected after SP-FGF1 transfection was due to secreted FGF1. Neutralization of exogenous FGF1 in control RPE cell cultures resulted in inhibition of FGFR1 autophosphorylation (Figure 4b ), con®rming that FGFR1 activation was due to the presence of FGF1 in the extracellular culture medium. The involvement of ERK2 activation in the proliferation of exogenous FGF1 cells (Guillonneau et al., 1998a) , led us to investigate the activation of ERK2 as a downstream pathway in the proliferation of transfected RPE cells. ERK2 activation was detected by reduced electrophoretic mobility and Western blotting, using an antibody that speci®cally recognized ERK2. A basal level of ERK2 activation was observed in control and FGF1 cells due to serum stimulation (Figure 4c ). In contrast, strong ERK2 activation was detected within 10 min in SP-FGF1 cells and reached a plateau over the next 2 h of culture. ERK2-P/ERK2 ratios were 40 ± 50% over this period of culture. After 6 h, ERK2 activation decreased (ERK2-P/ERK2 ratio: 15%). No ERK2 activation was detected after 24 h of culture Figure 2 Kinetics of FGF1 production, FGF1 secretion and FGF1 intracellular location in control and FGF1-expressing RPE cells. Total protein extracts (50 mg; a) and culture medium (48 ml; b) from control, FGF1-transfected (FGF1) and SP-FGF1 (SP-FGF1)-transfected RPE cells prepared on the day indicated after transfection were used for each Western blotting. Control, FGF1-transfected and SP-FGF1-transfected cells were ®xed in PAF and immunolocalization of FGF1 was performed as described in Materials and methods (c). Note that no FGF1 staining was observed in control RPE cells, whereas diuse cytoplasmic and nuclear FGF1 staining, and strong nuclear FGF1 staining were observed in SP-FGF1-transfected cells. The immunostaining shown is representative of four independent experiments (data not shown). We added a neutralizing anti-FGF1 antibody to the culture medium to check that the eects of secreted FGF1 on activation of the MAP kinase pathway was mediated by an autocrine/paracrine stimulation. The state of MAP kinase phosphorylation was investigated by Western blotting, using an antibody that speci®cally recognized active ERK1 and 2 (ERKs-P). In SP-FGF1 cells, the neutralization of secreted FGF1 resulted in the inhibition of ERK1 and 2 phosphorylation (Figure 4c ), demonstrating that ERK activation was mediated by secreted FGF1. MEK1 catalyses the phosphorylation of ERK2, resulting in ERK2 activation. The inhibition of MEK1 activity by PD 98059, which prevents the activation of ERK2, inhibited the proliferation of SP-FGF1 cells (Figure 4d ), suggesting that the proliferation of SP-FGF1 cells induced by secreted FGF1 was mediated by ERK2 activation. These data strongly suggest that the strong proliferation of SP-FGF1-transfected RPE cells was induced by high levels of secreted FGF1 and was mediated by sustained FGFR1 autophosphorylation and strong but transient ERK activation.
RPE cells resist to apoptosis through FGF1 secretion and the sustained activation of ERK2 Forty-eight hours after transfection, RPE cells were transferred to serum-free medium and cultured for 7 days. We used the TUNEL method to detect PCD at the single cell level and found that, on day 1 of serum-free culture, less than 1% of the nuclei of control cells were TUNEL-labelled (Figure 5a ). Transfection with SP-FGF1 and FGF1 cDNAs did not aect the level of RPE cell apoptosis detected on day 1 of culture. These results are similar to those obtained for cells cultured in the presence of serum (Guillonneau et al., 1998b) . The number of control cells undergoing PCD tripled on day 3 and was 15.6 times and 25 times higher on days 5 and 7 respectively than the basal level of PCD in cells on day 1 of culture ( Figure 5a ). FGF1 cells cultured in the absence of serum underwent PCD signi®cantly less rapidly than control cells. Serum depletion had no eect on cell apoptosis during the ®rst 3 days of culture. The frequency of PCD then increased slowly and was 4.2 and 9.8 times higher on days 5 and 7 respectively than the basal level of PCD on day 1 of culture. Surprisingly, the number of cells undergoing PCD increased much faster in SP-FGF1 cells after serum withdrawal than in control cells. As early as day 3, a large increase in the number of cells undergoing PCD was evident. The number of cells undergoing PCD was 25 times higher on day 3, 46.3 times higher on day 5 and 75.7 times higher on day 7 than the basal level of PCD in cells on day 1 of culture. No signi®cant cell proliferation was detected in any of the cultures in the absence of serum (data not shown). Cell survival may be controlled by the amount of FGF1 produced (Renaud et al., 1996) and released into the culture medium (Guillonneau et al., 1998b) . We therefore used Western blotting to test for the presence of FGF1 produced and secreted by FGF1 and SP-FGF1 cells cultured in the absence of serum. As previously reported (Guillonneau et al., 1998b) , very small amounts of FGF1 were detected in the serumfree culture media of RPE cells over the 7-day period of culture. In contrast, from day 2 onwards, FGF1 cells secreted sustained high levels of FGF1 in serum free-conditions. Large amounts of FGF1 were detected in the culture medium of SP-FGF1 cells (Figure 5b ), but surprisingly, the amounts of secreted FGF1 decreased rapidly from day 1 to day 4. SP-FGF1 cells stop secreting FGF1 after day 4 of the culture period. Neutralization of secreted FGF1 greatly increased PCD in FGF1 cells, as shown by the TUNEL method, suggesting that the decrease in cell apoptosis was due to the release of FGF1 (Figure 5c ). In contrast, the neutralization of secreted FGF1 did not aect PCD of SP-FGF1 cells.
The apparently contradictory data on the eects of FGF1 on cell survival in FGF1-transfected cells and SP-FGF1-transfected cells led us to explore the activation of FGFR1 by FGF1 during RPE cell apoptosis. We assessed the autophosphorylation of FGFR1. Similar levels of FGFR1 tyrosine phosphorylation were found in FGF1 and SP-FGF1 cells ( Figure 5d ). We investigated whether FGFR1 autophosphorylation was due to the release of FGF1 into the culture media of FGF1 and SP-FGF1 cells. The neutralization of FGF1 in the culture medium inhibited FGFR1 autophosphorylation in both FGF1 and SP-FGF1 cells. Thus, the dierence in PCD levels between FGF1 and SP-FGF1 cells was almost certainly not due to a dierence in FGFR1 activation. No signi®cant dierence in FGFR1 production was detected by Western blotting between FGF1 and SP-FGF1 cells and control cells (data not shown).
In PC12 cells, the trophic activity of endogenous FGF1 is ERK2 activation-independent (Renaud et al., 1996) , whereas an overactivation of ERK2 correlated with cell survival has been observed in RPE cells during ageing (Guillonneau et al., 1998b) . We therefore assessed ERK2 phosphorylation after serum withdrawal in FGF1-and SP-FGF1 cells by Western blotting, using an antibody that speci®cally recognized active ERK1 and 2. Basal ERKs phosphorylation was detected in control RPE cells (Figure 6a) . Surprisingly, strong and sustained activation of ERKs was observed over 5 days in FGF1 cells. In contrast, only a weak The state of ERK2 phosphorylation was investigated by reduced electrophoretic mobility and Western blotting, using an antibody that speci®cally recognized ERK2 (top of the ®gure). The eects of FGF1 neutralization on ERK1 and 2 activation were analysed by Western blotting, using an antibody that speci®cally recognized active ERK1 and 2 (ERKs-P) in SP-FGF1 cells cultured in the presence and absence of neutralizing anti-FGF1 antibody. (d) Cell proliferation of cells cultured in the presence and absence of 10 mM MEK inhibitor (Mek inh) was analysed as previously described in Materials and methods. These experiments were repeated three times with similar results in each case activation of ERKs was observed in SP-FGF1 cells. We analysed the eects of FGF1 neutralization on ERK 1 and 2 activation by Western blotting. The addition of a neutralizing anti-FGF1 antibody to the culture medium of FGF1 cells greatly reduced ERK1 and 2 phosphorylation (Figure 6b ), suggesting that the sustained activation of ERKs was due to the continuous secretion of FGF1. We investigated the role of ERKs activation in the eects on survival of secreted FGF1 in FGF1 cells, by treating cells with the MEK1 inhibitor. MEK1 inhibition resulted in a rapid increase in cell apoptosis. PCD increased by factors of 6 and 4.6 on days 5 and 7 respectively (Figure 6c ). These data strongly suggest that the eects on survival of the FGF1 secreted by FGF1 cells involves long-term ERKs activation.
The production of Bcl-x, mediated by ERK2 activation, is a key mechanism in the protective activity of FGF1
The mechanisms and proteins involved in the survivalprolonging activity of FGFs are largely unknown, but an increase in ERK2 production is correlated with cell survival during in vitro ageing for RPE cells and human cancer cells (Sivaraman et al., 1997; Guillonneau et al., 1998b ). We, therefore tested whether ERK2 overproduction was sucient to result in cell survival in serum-depleted RPE cell cultures. RPE cell transfection with ERK2 cDNA resulted in a 2 ± 5 times more ERK2 level from days 3 to 5, relative to control and FGF1 cells (Figure 7a ). However, ERK2-transfected cells were less resistant to apoptosis induced by serum depletion than FGF1 cells (Figure 7a ). We investigated whether ERK2 was essential for endogenous FGF1-mediated RPE cell survival using an antisense strategy to deplete ERK2. The treatment of FGF1 cells with antisense ERK2 ODNs speci®cally inhibited ERK2 production by 71 ± 83% over 5 days (data not shown) but had no signi®cant eect on the apoptosis of FGF1 cells before day 3 of culture ( Figure 7b ). The level of cell apoptosis was six times higher on days 3 and 5 for antisense than for sense ODNs. Thus the overproduction of ERK2 was not sucient to rescue RPE cells from apoptosis and the cell survival-promoting activity of FGF1 was controlled by the level and the kinetics of ERK2 activation rather than of ERK2 production in FGF1 cells.
Evidence exists for Bcl-2-dependent and Bcl-2-independent mechanisms in anti-apoptotic processes (Karsan et al., 1997) . Many members of the Bcl-2 family, including Bcl-x are also potent inhibitors of cell apoptosis. The production of Bcl-2 and Bcl-x was analysed by Western blotting in FGF1 cells. The overproduction of FGF1 had no signi®cant eect on Bcl-2 production in RPE cells (data not shown). In contrast, from day 2 onwards, two to three times more Bcl-x was consistently detected in FGF1-transfected cells than in SP-FGF1 cells (Figure 7c ) and control (Figure 7c ), indicating that Bcl-x synthesis induced by FGF1 was mediated by ERK2 activation in FGF1 cells. Finally, we tested whether Bcl-x was a key component in the control of FGF1 survival-promoting activity, by depleting Bcl-x in FGF1 cells using an antisense ODN approach. Treatment of RPE cells with an antisense Bcl-x ODN that speci®cally and completely inhibited Bcl-x production and de novo synthesis over 5 days (Bryckaert et al., 1999) , caused a large increase in PCD (Figure 7d ). Antisense Bcl-x ODNs gave a 4.5 times more apoptosis in FGF1 cells on days 3 and 5, than sense Bcl-x ODNs. The frequency of PCD in ERK2 ODN antisense-treated FGF1 cells was higher than that in Bcl-x ODN antisense-treated FGF1 cells (compare Figure 7b,d ). This suggests that other anti-apoptotic molecules stimulated by ERK pathway may be involved in the protective eect of FGF1 in FGF1 cells.
Discussion
Endogenous FGF1-mediated RPE cell proliferation requires FGF1 secretion and various FGF1 signalling pathways Although exogenous FGF1 is a potent mitogen for a wide variety of mesoderm-and neuroectoderm-derived cells in vitro, the transforming ability and oncogenic potential of this growth factor is highly dependent upon cell type, the level of synthesis and on whether or not it is secreted (Basilico and Moscatelli, 1992) . The overproduction of FGFs and FGFRs in cancer cells suggests that the autocrine and paracrine stimulation of cells may play a major role in cancer progression. It has been suggested that other members of the FGF family (FGF3-6) are involved in malignant autocrine transformation due to the presence of a signal peptide, which may be required if a growth factor is to act as a transforming oncogene (Yayon and Klagsbran, 1990) . High levels of FGF1 in RPE cells are correlated with various proliferating RPE diseases. However, it is not known whether FGF1 must be secreted to induce RPE cell proliferation. We studied the eects of FGF1 secretion on RPE cell proliferation by constructing and expressing a signal-sequence-FGF1 chimera using the signal sequence of human interferon. The presence of the signal sequence in the resulting fusion protein results in the secretion of FGF1 into the extracellular medium of RPE cells cultured in the presence of serum. Our results are consistent with those of a previous study (Forough et al., 1993) . Jouanneau et al. (1991) showed that secreted FGF1 was associated with the extracellular matrix of transfected cells. This apparent dierence in extracellular location (extracellular matrix versus culture medium) of secreted FGF1 may re¯ect dierences between the cell types producing the growth factor. Heparan-sulphate proteoglycans (HSPG) present at the cell surface of transfected cells have been shown to control the extracellular distribution of FGF1, because the addition of heparin prevents the binding of secreted FGF1 to extracellular HSPG (Cao et al., 1993) . Primary cultures of RPE cells have few proteoglycans at the cell surface and very few FGF1 low-anity binding sites related to HSPG (Guillonneau et al., 1996) . Thus, secreted FGF1 may be preferentially located in the extracellular culture medium of SP-FGF RPE cells due to the small number of FGF1 low-anity sites. The possible involvement of HSPG in the dierences in FGF1 mitogenic activity observed in dierent studies using FGF1-transfected cells remains a matter of speculation. The possible involvement of HSPG in FGFs-induced signalling remains a matter for debate because independent studies have shown that HSPG binding to FGFs is both essential and non-essential for a biological response to FGFs (Rapraeger et al., 1991; Roghani et al., 1994; Guillonneau et al., 1996) .
Data for the secretion of FGF1 in transfected cells contrast with those of FGF2 secretion studies using similar strategies involving the use of signal sequences, which did not yield soluble extracellular forms of FGF2 (Blam et al., 1988) . Conversely, the transfection of RPE with the FGF1 cDNA devoid of a sequence encoding a signal peptide led to the retention of FGF1 within the cell. In this study, we show that RPE cells that secreted FGF1 proliferated more rapidly than cells that did not secrete FGF1. They were disorganized and sometimes multilayered, suggesting a lack of contact inhibition, a characteristic of transformed cells. These data con®rm previous reports that FGF1 transforms cell lines that produce large amounts of FGF1 (Jaye et al., 1988) and the acquisition of motility and invasive potential in secreted FGF1-transfected epithelial cell lines (Jouanneau et al., 1991) . These results from previous studies and the results presented here suggest that FGF1 may also have metastatic potential in SP-FGF1-transfected cells. In the nature SP-FGF1 does not exist. High levels of FGF1 in RPE are correlated with RPE diseases. It would be of value to analyse FGF1 production in RPE cells and FGF1 release in RPE-associated choroidal melanomas. In sharp contrast to SP-FGF1-transfected epithelial cells, FGF1-transfected RPE cells did not secrete FGF1 in the presence of serum and kept their classical epithelial morphology and did not proliferate, consistent with the existence of a paracrine loop in the proliferation and transformation of RPE cells. High amounts of exogenous FGF1 have been detected in preretinal membranes, and in vitreous and subretinal¯uid cells from patients with proliferative vitreoretinopathy (Baudouin et al., 1993) . This demonstrates the secretion of the endogenous form of FGF1 and suggesting a role of the normal biological form of the Figure 7 Eects of ERK2 transfection, and of ERK2 and Bcl-x depletion on programmed cell death in control and FGF1-transfected, serum-depleted, long-term cultures of RPE cells. RPE cells were transfected with ERK2 cDNA and were transferred, 72 h after transfection to serum-free conditions for a 5-day period of culture. Programmed cell death was then analysed by the TUNEL method as described in Materials and methods (a). Seventy-two hours after transfection with FGF1 cDNA, con¯uent FGF1-transfected RPE cells were treated with Bcl-x sense and antisense ODNs (b) or with ERK2 sense and antisense ODNs (d) and cultured in serum-free conditions for 5 days. Bcl-x production in FGF1-transfected RPE cells cultured in serum-free medium in the presence and absence of Mek1 inhibitor was analysed by Western blotting (c). The data are representative of three independent experiments that gave similar results. Values are means+s.d. and dierences between means were analysed by the Mann ± Whitney test, **P50.01, ***P50.005
Signal peptide controls proliferation and survival activities of endogenous FGF1 M Bryckaert et al growth factor in the retina. This does not rule out the implication of other retinal mitogens having classical signal sequence to direct their secretion. Recently, proto-oncogenes have been detected in proliferative vitreoretinal diseases (Ren et al., 2000) , suggesting that FGF1 is not the only mitogen implicated in proliferative vitreoretinopathy. In addition, exogenous FGF1 was also detected associated with the extracellular matrix of the retina in the absence of any RPE proliferative pathology (Mascarelli et al., 1989) , showing that exogenous FGF1 is not always associated with cell proliferation. This could be due to the trapping of exogenous FGF1 by FGF-binding proteins like the soluble form of FGFR and HSPG (Guillonneau et al., 2000) . Another possibility is that endogenous FGF1 may activate by an intracrine mode of action, retinal cell proliferation under particular conditions like oxidative stress and nutriment deprivation.
Little is known about the mechanisms underlying RPE cell proliferation. However, the ability of secreted FGF1 and endogenous FGF1 to stimulate intracellular signalling during RPE cell proliferation has not been investigated before. In this study, autophosphorylation of FGFR1 was detected in SP-FGF1 cells cultured in the presence of serum, but not in FGF1 cells. This demonstrates the importance of the FGFR activation and shows that activation of a paracrine loop in FGF1 signalling is involved in the increase in cell proliferation. A speci®c neutralizing anti-FGF1 antibody abolished the increase in the proliferation, excluding the possibility of a paracrine loop involving another member of the FGF family. The initiation of DNA synthesis by FGFs requires the target cell to be continuously exposed to exogenous FGFs throughout the G1 phase of the cell cycle (Zhan et al., 1993) . Thus, the continuous secretion of FGF1 by SP-FGF1 RPE cells may induce an increase in cell proliferation via sustained FGFR1 autophosphorylation. Throughout the G1 phase, the receptor-mediated uptake of exogenous FGF1 results in the participation of FGF1 between the nucleus and the cytosol (Wiedlocha et al., 1994) . The role played by long-term activation of FGFR1 in the proliferation induced by secreted FGF is consistent with previous studies showing that if FGF1 is arti®cially targeted to the nucleus in the absence of FGFR, DNA synthesis is not accompanied by cell proliferation, unless FGFR is expressed in the cell before the addition of FGF1 (Widlocha et al., 1994) . During the proliferation of SP-FGF1 cells, FGF1 was predominantly associated with the nucleus, consistent with evidence showing that both tyrosine phosphorylation and the nuclear translocation of FGF1 are required to stimulate cell proliferation (Imamura et al., 1994) . No dierence in proliferation was observed between FGF1 cells and control cells and FGF1 was not preferentially located in the nucleus rather than the cytosol. This con®rms that exogenous FGF1 is translocated to the nucleus more eciently than endogenous FGF1 and suggests that the nuclear translocation of exogenous FGF1 is involved in the stimulation of cell proliferation.
In previous studies, we showed that RPE cell proliferation stimulated by exogenous FGF1 induced biphasic activation of ERK2 (Guillonneau et al., 1998a) . The ®rst phase consisted of transient (over a few minutes) but strong ERK2 activation, and the second was more sustained (2 ± 6 h) but weak. In FGF1 cells and control RPE cells with a low level of proliferation, ERK2 activation was very weak and corresponded to serum stimulation, whereas ERK2 activation was intense and sustained (over 6 h) in strongly proliferating SP-FGF1 cells. This suggests that the dierences in ERK2 kinetics re¯ects dierences in the rate of proliferation between FGF1 cells and SP-FGF1 cells. The regulation of growth factor-induced biological activities by the level and duration of ERK activation referred to as`whispering or shouting', has been observed in PC12 cell lines and may be involved in control and regulation of the proliferation of RPE cells expressing dierent forms of FGF1. It is possible that secreted FGF1 and exogenous FGF1 are translocated to the nucleus via dierent intracellular pathways. It has recently been suggested that an unknown component present in the nucleus interacting with FGF1, might be required for the production of fully mitogenic FGF1 (Klingensberg et al., 1999) . The translocation of FGF1 and FGF2 during the transition between G0 and G1 correlated with an increase in the transcription of ribosomal genes and resulted in the phosphorylation of nucleolin, whereas FGF2 has been shown to bind to casein kinase II (Bouche et al., 1987; Bonnet et al., 1996) . These data show clearly that FGFs act directly on the nucleus, in addition to stimulating the ERK pathway to induce cell proliferation. The speci®c nuclear location of FGF1 in the proliferating SP-FGF1-transfected RPE cells suggests that the nuclear transport of exogenous FGF1 may be directly involved in signalling in the mitogenic pathway mediated by internalized FGF1 as previously shown by Lin et al. (1996) .
In conclusion, this study clearly demonstrates for the ®rst time that, in addition to the secretion of FGF1, two intracellular events seem to be required to induce the hyperproliferation of FGF1-expressing RPE cells: (1) the long-term phosphorylation of FGFR1 by secreted FGF1 and (2) the long-term activation of ERK2 by secreted FGF1. These two intracellular events seem to impose another level of control on the mitogenic activity of FGF1. However the precise nature of the early genes induced by ERK2 and the target molecules of FGF1 in FGF1-expressing RPE cells are unknown.
The reduction of apoptosis mediated by endogenous FGF1 requires FGF1 release in non-proliferating RPE cells RPE cell apoptosis has been shown to be the suicide mechanism involved in human age-related macular degeneration and in in vitro and in vivo models of RPE cells (Hinton et al., 1998) . The widespread presence of FGFs and FGFRs in non-dividing cells suggests that FGF signalling may be involved in cell survival without inducing cell proliferation. In retinal dystropy in rat, cell apoptosis is prevented by a single injection of exogenous FGF1, demonstrating that FGF1 can act as a survival-promoting trophic factor in the retina in vivo (Faktorovich et al., 1990) . However, little is known about the mode of action and the mechanism underlying FGF-induced cell survival. However, recent studies have shown that FGF1 and 2 may induce or potentiate cell apoptosis, introducing confusion into our understanding of the biological eects of FGFs (Wang et al., 1998; Speer et al., 1998; Fenig et al., 1999; Maloof et al., 1999) .
In culture, primary RPE cells produce very low basal levels of FGF1 and rapidly die by apoptosis after serum depletion. It has been shown that the neutralization of secreted FGF1 by RPE cells induces more rapid cell apoptosis, suggesting a role for secreted FGF1 in RPE cell survival (Guillonneau et al., 1997) . Surprisingly, in this study, we show that SP-FGF1 cells, proliferate actively in the presence of serum and then die rapidly after 3 days of culture in the absence of serum. Cell apoptosis does not seem to be due to the absence of FGF1 production, but due to the rapid break in the secretion of FGF1. In contrast, FGF1 cells, which proliferated less rapidly and did not secrete FGF1 in the presence of serum, were resistant to serum depletion-induced apoptosis. Surprisingly, FGF1 cells secreted FGF1 in the absence of serum. So far, no mechanism for the release of FGF1 from intracellular sources has been accepted, but several have been proposed. The active secretion of FGF1 from FGF1-transfected NIH3T3 ®broblasts can be induced by temperature stress (Jackson et al., 1992) . Alternatively, FGF1 may be released due to a transient change in cell membrane permeability in oxidised LDL-treated cells (Ananyeva et al., 1997) . Intense light and exposure to oxidising agents increase FGF2 mRNA levels in RPE cells, consistent with the notion that FGF2 acts as a survival factor (Hackett et al., 1997) . In our study, we exclude an eect of FGF2 by using a speci®c neutralizing anti-FGF1 antibody. FGF1 cells resisted serum depletion-induced apoptosis, secreted sustained levels of FGF1, showed sustained levels of FGFR1 autophosphorylation and sustained ERK2 activation (over a few days). Our data are consistent with previous data showing that 1-cell resistance to apoptosis results from long-term FGFR1 autophosphorylation and ERK2 activation during RPE cell senescence (Guillonneau et al., 1998b) and 2-the production and the activation of ERK proteins are important for cell survival (Mishima et al., 1998; Yazlovitskaya et al., 1999) . Thus, this study demonstrating the importance of long-term ERK2 activation in the resistance of RPE cells to apoptosis is consistent with recent studies showing that the acute activation of the ERK cascade by growth factors potentiates proliferation whereas a chronic increase in ERK activity is cytoprotective (Carter et al., 1998) .
Long-term induction of Bcl-x synthesis mediated by the sustained activation of ERK2 is one of the major pathways involved in the promotion of survival by the signal-less form of FGF1 in RPE cells
The overproduction of ERKs is required for cell survival in human breast cancer (Sivaraman et al., 1997) . Cell survival is also correlated with the overproduction of ERK2 during ageing of RPE cells (Guillonneau et al., 1998) . In this study, we demonstrated that the overproduction of ERK2 alone, without overproduction of FGF1, did not result in RPE cell survival after serum depletion, suggesting that other pathways are required to mediate cell survival. Conversely, the down-regulation of ERK2 induced rapid and extensive apoptosis in FGF1 cells cultured in the absence of serum, demonstrating that FGF1 signalling in protection against apoptosis is mediated by the ERK2 cascade.
Little is known about the mechanisms and proteins involved in the survival-promoting activities of FGFs. It has been shown that the ERK pathway is necessary for the IGF survival eect in adipocytes (Navarro et al., 1998) . This eect is associated with inhibition of the production of Bcl-xs, the pro-apoptotic form of Bcl-x. It is believed that the balance between death agonists and antagonists belonging to the Bcl-2 family may regulate apoptosis. Unlike Bcl-2, Bcl-x1, the antiapoptotic long form of Bcl-x, is very abundant in the adult retina. The pivotal role of Bcl-x was recently demonstrated in eosinophil cultures, in which GM-CSF rescued apoptosis by up-regulating Bcl-x, whereas no stimulation of Bcl-2 was observed (Konig et al., 1997) . We found that overproduction of FGF1, but not of SP-FGF1, induced an increase in the production of Bcl-xl, in RPE cells. Bcl-xl production is mediated by ERK activation in FGF1-transfected RPE cells, indicating that the ERK pathway is involved in activation of the anti-apoptotic Bcl-x pathway. The precise mechanism by which Bcl-x expression is regulated is unknown in other cell types. Recent data have shown a link between endogenous FGF1 signalling and the production of Bcl-2 in neuronal cell survival (Raguenez et al., 1999) . We did not detect an increase in the production of Bcl-2 protein in FGF1-transfected RPE cells during serum deprivation, suggesting that the various members of the Bcl-2 anti-apoptotic family have cell type-speci®c eects. Bclxl is thought to be expressed in long-lived post-mitotic cells whereas Bcl-2 is expressed predominantly in proliferating cells in adult animals. In conclusion, our results provide insight into the proliferation and survival activities of FGF1 which depend on the secretion of FGF1, and which is determined by the conditions of cell culture. Cell proliferation was SPdependent, whereas cell survival was not. The signal peptide controls the level and duration,`whispering or shouting', of ERK2 activation cells which determines FGF1 biological activities. A better understanding in the regulation of the various pathways mediated by the dierent members of the FGF family may have important implications for anti-degenerative and anticancer treatments.
Materials and methods
Cell culture, transfection of RPE cells and treatment of the transfected RPE cells
Bovine RPE cells were isolated as previously described (Guillonneau et al., 1997a) . Primary RPE cell cultures were grown in Dulbecco's modi®ed essential medium (DMEM, GIBCO/BRL, New York, USA) containing 10% foetal calf serum (FCS, GIBCO/BRL, 2.5 mg/ml fungizone, 50 mg/ml gentamycin, 2 mM L-glutamine.
Primary cultures of RPE cells were incubated for 3 days with 10% heat-treated (568C for 45 min) calf serum. Then, the typically 50% con¯uent RPE cells were transiently cotransfected in the absence of serum using 7 mg/ml lipofectin (GIBCO BRL, Cergy Pontoise, France), the p-Hook-1 vector (Invitrogen, Groningen, Netherlands) and the FGF1 expression vector (pSVL-FGF1 1 ± 134) which encodes the 16 kDa FGF1 as previously described (Renaud et al., 1996; Chesnut et al., 1996) . A similar construct (pSVL-SP-FGF1), containing the FGF1 cDNA, downstream from a heterologous SP sequence coding for the 21-amino acid signal peptide also used for transfection. This construct encodes a protein consisting of the SP of human ®broblast interferon fused to the ®rst residue of FGF1, as previously described (Jouanneau et al., 1991) . Control cells consisted of RPE transfected with the human expression vector pHook-1 alone. The pHook-1 vector allows the selection of a homogenous population of transiently transfected cells, using the Capture-Tec system (Invitrogen, Groningen, Netherlands). Six hours after transfection, RPE cells were placed in serum-containing culture medium for 24 h. Then, transfected cells were selected from total populations in culture by virtue of their ability to bind to coated magnetic beads as previously described (Chesnut et al., 1996) . Cell proliferation was analysed over a 72-h culture period. Con¯uent transfected cells were transferred to serum-free culture medium and cultured for 7 days, to analyse the eect of transfection with FGF1 on cell survival.
In some experiments, anti-FGF1 neutralizing polyclonal antibody (R&D Systems Europe, Oxon, UK), anti-FGFR blocking monoclonal antibody (clone VBS1, Chemicon International) and the MEK inhibitor, PD098059 (Calbiochem, Meudon, France), were added on days 1 and 3 to ®nal concentrations of 200 mg/ml, 20 mg/ml and 20 mM respectively. The speci®city of the anti-FGF1 and anti-FGFR1 antibodies has been demonstrated and the MEK inhibitor had no non-speci®c cytotoxic eects, as previously reported (Guillonneau et al., 1998b (Guillonneau et al., 1998b) . The cells were then lysed in Triton X-100 lysis buer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 50 mM NaF, 5 mM EDTA, 40 mM b-glycerophosphate, 0.2 mM sodium orthovanadate, 1 mg/ml leupeptin, 1 mM pepstatin A and 1% Triton X-100). Cell lysates (equal amount of protein) were then immunoprecipitated with 1 mg of polyclonal anti-FGF1 antibodies (Sigma, Saint Quentin Fallavier, France). Protein G-Sepharose beads (50 ml v/v) were added and incubated with the mixture for 1 h at 48C. Immune complexes were collected by centrifugation at 12 000 g. The immunoprecipitated proteins were separated by SDS ± PAGE (15% polyacrylamide gel). The protein bands detected by autoradiography were quanti®ed using an LKB Ultrascan XL laser densitometer (Pharmacia, Gaithersburg, MD, USA). The FGF1 secreted into the culture medium was analysed using heparin-Sepharose columns as previously described (Guillonneau et al., 1998a) .
Cell proliferation and cell death assays
The status of proliferating and quiescent cells was determined as previously described (Guillonneau et al., 1998b) . The proliferation of RPE cells was assessed daily by counting the number of cells and by determining [ The number of dead cells was determined by counting the cells remaining in the culture dish after staining with trypan blue and MTT (3(4,5-dimethylthiazol-, yl) 2,5 diphenyltetrazolium bromide). We checked daily for cells undergoing programmed cell death (PCD), which were counted by two methods: (1) terminal d'UTP nick end labelling (TUNEL), (PCD kit, Boehringer, Meylan, France) and (2) staining of the nuclei with Hoechst 33258 (0.5 mg/ml) after ®xation of the cells with 4% paraformaldehyde and permeabilization with ice-cold ethanol.
Oligonucleotides and oligonucleotide treatment of the cells
Phosphodiester sense and antisense oligonucleotides (ODNs) directed against ERK2 were designed based on the published sequence of the mouse ERK2 gene (Her et al., 1991) . The sequence of this ODN was identical to those of ERK1 and ERK2 conserved in human, mouse and rat. The antisense ODN was 5'-GCC-GCC-GCC-GCC-GCC-AT-3' (referred to as AS-ERK) and the corresponding sense ODN was 5'-ATG-GCG-GCG-GCG-GCG-GC-3' (referred to as S-ERK). Two phosphodiester sense and antisense ODNs directed against Bcl-x were designed based on the published sequence of the human Bcl-x (hBcl-x) gene (Boise et al., 1993) . The 16-mer used correspond to the start codon (ATG) plus the 13 bases immediately downstream in the hBcl-x, as previously published by Amarante-Mendes et al. (1998) . The antisense ODN was 5'-CCGGTTGCTCTGAGACAT-3' (referred to as AS-Bcl-x) and the corresponding sense ODN was 5'-ATGTCTCAGCAACCCGG-3' (referred to as S-Bcl-x). 3' exonucleases are thought to be more active than 5' exonucleases, so an amine group was added at the 3'-end, as this modi®cation has been shown to increase the stability of classical phosphodiester antisense ODNs (to levels similar to those for phosphorothioate ODNs) and of the ODNstarget complex. These 3'-modi®ed ODNs are also not toxic and do not compete with FGF1 and 2 for their binding sites (heparin-like activity), whereas full phosphorothioate ODNs do (Fennwald and Rando, 1995; Guvakova et al., 1995) . All ODNs were synthesized commercially (Eurogentec, Seraing, Belgium) and puri®ed by HPLC. The results presented here were obtained with 35 mM ODNs for ERK and 25 mM ODNs for Bcl-x, and with 5 mg/ml of lipofectin for cells incubated in the absence of serum. Cells were incubated for 3 days in the presence of 10% heat-treated (568C for 45 min) calf serum. RPE cells were then treated with ODNs/lipofectin for 12 h. Fresh serum-free medium was added and the cells were cultured for 7 days. On day 2 of serum-free culture, the appropriate concentration of ODN was added in the presence of lipofectin. For 3 days, beginning on day 4 of incubation, cells were treated with the appropriate concentration of ODN without lipofectin. The diusion of ODNs in RPE cells was studied using ODNs with cyanin 3 groups coupled to the 5'-terminus. These¯uorescent ODNs were detected with an Aristoplan microscope (Leica, Rueil-Malmaison, France). ODN uptake by cells was observed as early as 5 min after ODN/lipofectin treatment and 85 ± 99% of the cells were labelled after 6 h of exposure to ODN (nuclear and perinuclear location).
FGF1 mRNA levels
Total RNA was prepared from untransfected and transfected cells using the guanidium/isothiocyanate technique (Chomczynski and Sacchi, 1987) , and samples were analysed by RT ± PCR as previously described (DesireÂ et al., 1998) . Brie¯y, 1 mg of RNA and 170 pg of tobacco leaf nitrate reductase (NR) transcripts (as an internal control) were reversed transcribed. In preliminary experiments, we found that the linear phase of FGF1 ampli®cation corresponded to 28 ± 33 cycles (Renaud et al., 1996; DesireÂ et al., 1998) . Oligomers were designed based on dierent exons of the coding region of FGF1 to prevent the ampli®cation of genomic DNA. Speci®c oligomers were used for FGF1 ampli®cation: antisense primer 5'-TCC-GAG-GAC-CGC-GTT-TGC-AG-3' and sense primer 5'-GAT-CCT-TCC-GGA-TGG-CAC-AG-3'. A 295-bp fragment was generated. The NR-speci®c antisense primer 5'-GCT-GGA-TCC-ATT-GCA-AAT-TCC-3' and sense primer 5'-AGG-AGC-TGA-TGT-GTT-GCC-CGG-3' generated a 75-bp fragment. To check RNA quality, glyceraldehyde-3-phosphate deshydrogenase (GAPDH) was ampli®ed with the antisense primer 5'-ATG-GCA-TGG-ACT-GTG-GTC-AT-3' and sense primer 5'-ATG-CCC-CCA-TGT-TTG-TGA-TG-3', generating a 162-bp fragment.
The FGF1 and NR-ampli®ed products were subjected to electophoresis in a 1.8% agarose gel, blotted onto Hybond N + (Amersham, Les Ulis, France), and probed with speci®c internal 32 P-labelled oligonucleotides as previously described (Renaud et al., 1996) . X-Omat AR5 X-ray ®lm (Eastman Kodak Co. Rochester, NY, USA) were exposed to the membrane. The autoradiographs were digitized and the digitized images were quanti®ed with One-D Scan software (Scanalytics, Billerica, MA, USA). Results are expressed as the FGF1/NR ratio for each lane.
Western blot analysis
RPE cells were incubated in serum-free medium for 7 days. They were washed twice in PBS, lysed in ice-cold Triton X-100 lysis buer and centrifuged at 48C for 10 min at 10 000 g. Monoclonal antibody directed against b-actin was used as an internal standard for checking protein loading. The soluble proteins of the cell lysates were separated by SDS ± PAGE (12% polyacrylamide gel for ERK2 and 7% polyacrylamide gel for FGFR1), transferred onto nitrocellulose ®lters by electroblotting and probed with polyclonal antibodies directed against ERK2 and FGFR1 (Santa Cruz, Le Perray-en-Yvelines, France). The primary antibodies were detected with a horseradish peroxidase-conjugated goat antirabbit secondary antibody. ECL substrates were used to detect positive bands, according to the manufacturer's instructions, and the membrane was placed against Hyper®lm TM ECL (Amersham, Orsay, France). The protein bands detected on the¯uograph were quanti®ed using an LKB Ultrascan XL laser densitometer (Pharmacia, Saclay, France).
Immunohistochemistry
Transfected and untransfected RPE cells plated on glass coverslips in 12-well plates were ®xed with 4% paraformaldehyde, incubated with anti-FGF1 monoclonal antibody (1/ 100, Clone FA-88, Sigma, Saint Quentin Fallavier, France), or non-immune serum (1/100), in 0.1% Triton X-100. The antigen-antibody complexes were detected with rhodamine isothiocyanate anti-mouse monoclonal antibody (1/100, Sigma, Saint Quentin Fallavier, France).
Statistics
Each ®gure shows the results of experiments repeated at least three times. All data are expressed as the average+standard error of the mean. Statistical comparisons were made using two-tailed Student's t-tests (normal distributions with equal variances) and the Wilcoxon or Mann and Whitney test (nonparametric tests).
